SPO Medical Demonstrates Breakthrough Technology

Applications Include Sports and Wellness Products for the Consumer Market

NEW YORK, August 17 /PRNewswire-FirstCall/ -- SPO Medical Inc. (SPOM), a
leading developer of biosensor and microprocessor technologies for use in
portable monitoring devices, announced today that it has successfully
demonstrated to several leading sports and fitness watch manufacturers its
vital sign technology for measurement of the heart rate via a conventional
wrist watch, negating the need of the traditional chest strap currently used
by most sports watch manufacturers.
Demonstrations were performed using a wrist watch incorporating SPO's
proprietary and patented technology based on the reflectance of light. The
ability to accurately and reliably measure heart-rate from the wrist area
during motion has been a major challenge for the sports watch industry which
typically requires a chest-strap for acquiring heart-rate readings that are
generally displayed on a wrist watch.
Michael Braunold, President and Chief Executive Officer of SPO Medical
commented: "Monitoring the heart rate and its derivatives in sports and
general wellness applications without the need of a cumbersome and generally
uncomfortable chest-strap has eluded the industry since inception of the
professional sports watch. Our technology, when applied to a sports watch
will be a major advantage for many users, both men and women alike who find
the chest strap inhibitive to their sports or leisure activity and generally
uncomfortable. We have overcome technological hurdles as a result of several
years' of research and experience gained from our commercial medical product
line."
The worldwide annual market for sports watches incorporating a chest
strap is estimated in excess of US$1 Billion. The appeal in this market of a
wrist watch that does not require a conventional chest strap for measurement
of heart rate and the significance of product derivatives for the general
leisure and wellness market, create new opportunities worldwide for SPO.
Braunold continued: "Our goal is to engage leading manufacturers and to
develop together mass-market consumer product offerings that require heart
rate and other wellness derivative measurements during sport and general
leisure activities."
About SPO Medical:
SPO Medical (SPOM) a leading developer of biosensor and microprocessor
technologies for use in portable monitoring devices to capture life-saving
and life-enhancing information within four key markets: medical care; home
and remote-care; sports and wellness; and safety and security. Its patented
technology uses information gathered from the reflectance of light on the
human blood stream, in a non-invasive manner, to monitor key vital signs. The
Company distributes its products through a network of distributors and also
licenses its technologies to appropriate client corporations for
commercialization and distribution. For more information, visit
http://www.spomedical.com and http://www.spobaby.com.
Forward Looking Statements:
This press release contains forward-looking statements that involve
substantial uncertainties and risks. These forward-looking statements are
based upon our current expectations, estimates and projections about our
business and our industry, and that reflect our beliefs and assumptions based
upon information available to us at the date of this release. We caution
readers that forward-looking statements are predictions based on our current
expectations about future events. These forward-looking statements are not
guarantees of future performance and are subject to risks, uncertainties and
assumptions that are difficult to predict. Our actual results, performance or
achievements could differ materially from those expressed or implied by the
forward-looking statements as a result of a number of factors, including but
not limited to, market acceptance of our products and new product
applications, product performance, size of prospective markets, revenues
assessments, changes in economic conditions generally and the medical devices
market specifically, changes in technology, legislative or regulatory changes
that affect us, the sufficiency and availability of working capital, the
introduction of competing products, changes in our operating strategy or
development plans and the risks and uncertainties discussed under the heading
"Risk Factors" in Item 1 of our Annual Report on Form 10-K for the fiscal
year ended December 31, 2008. We undertake no obligation to revise or update
any forward-looking statement for any reason.
SPO Medical Contact: Jeff Feuer, Chief Financial Officer. Tel:
1-866-991-SPOM (7766) or email: investors@spomedical.com
SOURCE SPO Medical Inc

SPO Medical Contact: Jeff Feuer, Chief Financial Officer. Tel: 1-866-991-SPOM
(7766) or email: investors@spomedical.com